Mugusi et al identified predictors of mortality in patients coinfected with pulmonary tuberculosis and human immunodeficiency virus (HIV). These can help to identify a patient who may benefit from more aggressive management. The authors are from Muhimbili University of Health and Allied Sciences (Tanzania), Harvard School of Public Health, and the University of Munich.